blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3184543

EP3184543 - IMMUNOPOTENTIATOR CONTAINING ANTI-ANG2 ANTIBODY [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  01.11.2019
Database last updated on 18.11.2024
FormerExamination is in progress
Status updated on  03.07.2019
FormerRequest for examination was made
Status updated on  02.03.2018
FormerThe application has been published
Status updated on  26.05.2017
Most recent event   Tooltip01.11.2019Withdrawal of applicationpublished on 04.12.2019  [2019/49]
Applicant(s)For all designated states
Samsung Electronics Co., Ltd.
129, Samsung-ro
Yeongtong-gu
Suwon-si
Gyeonggi-do 16677 / KR
[N/P]
Former [2017/26]For all designated states
Samsung Electronics Co., Ltd
129, Samsung-ro
Yeongtong-gu
Suwon-si
Gyeonggi-do 16677 / KR
Inventor(s)01 / KANG, Yuhoi
B-916, 22, Neuti-ro
Bundang-gu
Seongnam-si Gyeonggi-do / KR
02 / LEE, Hojun
119-901, 346-1 Sangdo-ro
Dongjak-gu
Seoul / KR
03 / JO, Hongseok
301-1005, 90, Unam-ro
Osan-si Gyeonggi-do / KR
04 / PARK, Sang Chul
206-101, 11, Gungnae-ro
67beon-gil, Bundang-gu
Seongnam-si Gyeonggi-do / KR
05 / HAN, Sang Yeul
108-203, 15, Tapsil-ro
Giheung-gu
Yongin-si Gyeonggi-do / KR
 [2017/26]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[2017/26]
Application number, filing date16205331.820.12.2016
[2017/26]
Priority number, dateKR2015018645724.12.2015         Original published format: KR 20150186457
[2017/26]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP3184543
Date:28.06.2017
Language:EN
[2017/26]
Type: A3 Search report 
No.:EP3184543
Date:23.08.2017
Language:EN
[2017/34]
Search report(s)(Supplementary) European search report - dispatched on:EP20.07.2017
ClassificationIPC:C07K16/26, C07K16/22, A61K39/00
[2017/26]
CPC:
C07K16/22 (EP,US); C07K16/18 (US); A61K2039/505 (EP,US);
C07K2317/21 (EP,US); C07K2317/24 (EP,US); C07K2317/565 (EP,US);
C07K2317/622 (EP,US); C07K2317/74 (EP,US); C07K2317/75 (EP,US);
C07K2317/92 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/14]
Former [2017/26]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:IMMUNOPOTENZIATOR MIT ANTI-ANG2-ANTIKÖRPER[2017/26]
English:IMMUNOPOTENTIATOR CONTAINING ANTI-ANG2 ANTIBODY[2017/26]
French:IMMUNOSTIMULANT CONTENANT DES ANTICORPS ANTI-ANG2[2017/26]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure20.12.2016Date on which the examining division has become responsible
21.02.2018Amendment by applicant (claims and/or description)
21.02.2018Examination requested  [2018/14]
08.07.2019Despatch of a communication from the examining division (Time limit: M04)
25.10.2019Application withdrawn by applicant  [2019/49]
Fees paidRenewal fee
21.12.2018Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]US2015337033  (KIM SEOK KYUN [KR], et al) [Y] 1-14 * Examples, Tables 5, 6, 7, 8, 9, 10, 11, 15, paragraphs, 20, 39 *;
 [Y]  - ITALIA GRENGA ET AL, "Inhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack", JOURNAL FOR IMMUNOTHERAPY OF CANCER, (20151117), vol. 3, no. 1, doi:10.1186/s40425-015-0096-7, XP055357747 [Y] 1-7 * abstract *

DOI:   http://dx.doi.org/10.1186/s40425-015-0096-7
 [Y]  - S. B. COFFELT ET AL, "Angiopoietin 2 Stimulates TIE2-Expressing Monocytes To Suppress T Cell Activation and To Promote Regulatory T Cell Expansion", THE JOURNAL OF IMMUNOLOGY, US, (20110302), vol. 186, no. 7, doi:10.4049/jimmunol.1002802, ISSN 0022-1767, pages 4183 - 4190, XP055357255 [Y] 1-7 * abstract *

DOI:   http://dx.doi.org/10.4049/jimmunol.1002802
 [Y]  - KUEMPERS P ET AL, "The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus", ANNALS OF THE RHEUMATIC DISE, BRITISH MEDICAL ASSOCIATION, GB, vol. 68, no. 10, doi:10.1136/ARD.2008.094664, ISSN 0003-4967, (20091001), pages 1638 - 1643, (20081017), XP008114161 [Y] 8-14 * abstract * * Discussion *

DOI:   http://dx.doi.org/10.1136/ard.2008.094664
 [Y]  - ALEXANDER SCHOLZ ET AL, "Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation : Angiopoietin-2 and inflammation", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, US, (20150313), vol. 1347, no. 1, doi:10.1111/nyas.12726, ISSN 0077-8923, pages 45 - 51, XP055388983 [Y] 8-14 * page 47, column r, paragraph last *

DOI:   http://dx.doi.org/10.1111/nyas.12726
 [Y]  - NICTÉ FIGUEROA-VEGA ET AL, "Tie-2 Is Overexpressed by Monocytes in Autoimmune Thyroid Disorders and Participates in Their Recruitment to the Thyroid Gland", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, US, (20090701), vol. 94, no. 7, doi:10.1210/jc.2009-0220, ISSN 0021-972X, pages 2626 - 2633, XP055388843 [Y] 8-14 * Discussion *

DOI:   http://dx.doi.org/10.1210/jc.2009-0220
 [Y]  - LAWRENCE F. BROWN ET AL, "Expression of Tie1, Tie2, and Angiopoietins 1, 2, and 4 in Kaposi's Sarcoma and Cutaneous Angiosarcoma", AMERICAN JOURNAL OF PATHOLOGY., US, (20000601), vol. 156, no. 6, doi:10.1016/S0002-9440(10)65088-2, ISSN 0002-9440, pages 2179 - 2183, XP055388979 [Y] 8-14 * abstract *

DOI:   http://dx.doi.org/10.1016/S0002-9440(10)65088-2
by applicant   - SCHWABER, J; COHEN, E. P., "Human x Mouse Somatic Cell Hybrid Clones Secreting Immunoglobulins of Both Parental Types", NATURE, (1973), vol. 244, pages 444 - 447
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.